ArticleBMC microbiology2025

In vitro activity of Eravacycline against carbapenem-resistant gram-negative bacilli and associated risk factors for non-susceptible infections from a tertiary hospital in fujian, China from 2021 to 2024.

Xuyang Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.